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Abstract
The various layers of the extracellular matrix, forming the endomysium, perimysium and
epimysium of skeletal muscles, provide essential structural and mechanical support to
contractile fibres. Crucial aspects of muscle elasticity and fibre contractility are depend‐
ent on proper cell–matrix interactions. A complex network of collagen fibres, non-
fibrillar  collagens,  proteoglycans,  matricellular  proteins,  matrix  metalloproteinases,
adhesion receptors and signalling molecules maintain the physical structure for force
transmission within motor units, embed critical cellular structures such as capillaries and
motor  neurons,  and  enable  essential  sarcolemma-matrix  adhesion  processes  and
signalling cascades. The systems biological concept of protein complexomes, which
assumes the existence of interconnectivities between large protein assemblies, can be
readily applied to the proteins within the extracellular space of muscles. Recent proteomic
studies confirm that the extracellular matrix complexome has considerable influence on
the integrity and cellular functions of skeletal muscle fibres. Adaptations or changes in
the organization of the extracellular matrix play a crucial role during fibre regeneration
following injury, extensive neuromuscular activity or pathophysiological insults. This
chapter outlines the molecular components of the matrisome from skeletal muscles and
discusses the extracellular matrix in relation to myogenesis, maturation of motor units,
adaptation to changed functional demands and myofibrosis in muscular disorders.
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1. Introduction
In addition to the universal physiological, metabolic and regulatory challenges of almost all
cellular entities in the body, muscle tissues have to constantly adapt to a variety of biological
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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issues related to high energy demand, elevated levels of cellular stress and enormous physi‐
cal strains during excitation–contraction–relaxation cycles [1]. The survival of skeletal muscle
fibres therefore depends heavily on (i) a high degree of physiological adaptability, (ii) a unique
level of tissue plasticity, (iii) efficient molecular chaperoning to prevent proteotoxic insults and
(iv) a sophisticated repair machinery that can counter-act frequent cellular injuries [2]. A crucial
stabilizing element that is intrinsically involved in this continuous maintenance of contractile
tissues is the extracellular matrix (ECM) [3]. On the one hand, the complex layers of the muscle
ECM provide the physical structure for force transmission between contracting fibres and their
surrounding tissue environment [4], and on the other hand the ECM functions as an embed‐
ding medium for essential supportive components of muscles such as capillaries and motor
neurons [5].
The composition and organization of the ECM adapts considerably in response to changed
functional or structural demands during myogenesis, fibre maturation and exercise-induced
changes [6]. During the natural aging process and in association with a variety of muscular
disorders, a hyperactive connective tissue may trigger myofibrosis with a detrimental impact
on muscle elasticity and fibre contractility [7]. Physiological or pathological changes in the
muscle ECM frequently mirror the different phases of altered muscle structure and function
[8]. The main component of the ECM is represented by collagen, which exits in a large number
of isoforms that connect with proteoglycans, matricellular proteins and adhesion receptors to
form an elaborate extracellular network and tight cell–matrix interactions [9].
This chapter provides an overview of the molecular components of the ECM from skeletal
muscle and describes the proteomic concept of the ECM complexome. The formation, matu‐
ration and flexibility within the various layers of the ECM in developing, maturing and
adapting skeletal muscles is outlined, as well as the crucial role of myofibrosis in neuromus‐
cular pathology.
2. Molecular and cellular structure of the extracellular matrix
In skeletal muscles, the ECM is involved in a variety of processes during development,
contractile maturation, fibre regeneration following injury, physiological adaptations to
changed functional demands and the natural aging process [8]. As outlined in Figure 1, the
ECM is a highly dynamic non-cellular system that undergoes frequent cycles of modifications,
degradation and reassembly. The muscle ECM functions on the one hand as an embedding
and stabilizing structural support and on the other hand as a cellular interaction and signalling
medium. The molecular lattice of collagens and proteoglycans with its associated matricellular
proteins, enzyme systems and adhesion receptors mediates various physiological and
biochemical mechanisms, including (i) the overall maintenance of muscle tissue stability and
elasticity, (ii) the mechanical transduction of force from the contractile fibres to their anchoring
tissues, (iii) cytoskeletal coupling to enable the efficient execution of frequent excitation–
contraction–relaxation cycles, (iv) the provision of signalling pathways at the fibre periphery,
(v) the preservation of neuromuscular homeostasis, and (vi) the physical scaffold and embed‐
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ding medium of cellular constituents, such as contractile fibres, capillaries, motor neurons and
satellite cell pools. Cell–matrix interactions are of central importance during cell adhesion and
cell migration and thus essential during both embryonic and adult myogenesis.
Figure 1. Overview of the complex functions and interactions of the extracellular matrix from skeletal muscles.
The distinct layers of the ECM that surround muscle fibres, muscle fascicles and the entire
skeletal muscle are formed by the endomysium, perimysium and epimysium, respectively [3].
Figure 2 shows diagrammatically the arrangements of the ECM from skeletal muscles and lists
the main molecular constituents, including various isoforms of collagen, proteoglycans,
matricellular proteins, crosslinking proteins and matrix metalloproteinases. Crucial adhesion
systems that maintain sarcolemma–matrix interactions are marked. They include the collagen-
laminin-α/β-dystroglycan-dystrophin/utrophin axis and the collagen–fibronectin–integrin
axis that link the basal lamina via the plasmalemma to the underlying membrane cytoskeleton
[10].
The stabilizing linkage between the outside and inside of muscle cells, provided by the ECM–
sarcolemma–cytoskeleton axis, is of critical importance for maintaining normal contractile
functions [8]. Primary or secondary abnormalities in individual binding partners of these
surface complexes may result in severe neuromuscular disorders, as discussed in below section
on the role of the ECM in skeletal muscle pathology and myofibrosis.
Collagens form tight helical structures and function as the main structural protein species in
the extracellular space. Muscle-associated collagens are highly abundant in the interstitial
matrix, ECM microfibrils and the basal lamina [11]. Collagen isoform COL I, the most abundant
protein in the mammalian body [12], is the primary collagen in the perimysium and tendon.
The interstitial matrix contains mostly collagen COL I, COL III and COL V. Minor types of
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collagens in this extracellular region are COL XI, XII, XIV, XV and XVIII and are mostly
expressed during muscle development [3]. The main structural constituent in ECM microfibrils
is collagen isoform COL VI. Microfibrils provide structural support during the physical strains
of continuing contraction–relaxation cycles. Directly overlaying the sarcolemma membrane is
the basal lamina consisting of the main non-fibrillar collagen isoform COL IV and a few minor
constituents, including COL VI, XV and XVIII. The collagen network of the basement mem‐
brane interacts with two crucial plasmalemma adhesion complexes, the integrin complex and
the dystrophin–glycoprotein complex [10]. These sarcolemma-bridging protein assemblies
form the laminin–dystroglycan axis [13] and the fibronectin-integrin (α7β1) axis [14], whereby
Figure 2 Diagrammatic presentation of the various layers of the extracellular matrix (ECM) from skeletal muscle and
an overview of the molecular components that form the interstitial matrix, microfibrils and the basal lamina. Abbrevia‐
tions: COL, collagen; DG, dystroglycan; FN, fibronectin; LAM, laminin; INT, integrin; MMP, matrix metalloproteinase;
NMJ, neuromuscular junction; PG, proteoglycan; PRELP, proline-arginine-rich end leucine-rich repeat protein; SLRP,
small leucine-rich repeat proteoglycans; TIMP, tissue inhibitors of matrix metalloproteinases.
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the ECM glycoprotein fibronectin mediates the connection between laminin-211 (α2β1γ1
merosin) and collagen COL IV [15].
A variety of regulatory ECM proteins are involved in matrix assembly and the modulation of
cell–matrix interactions, such as dermatopontin, nidogen/entactin, periostin (osteoblast-
specific factor OSF-2) and osteopontin [16–18]. Matricellular proteins represent non-architec‐
tural ECM components and are crucial factors during muscle development and fibre repair.
Matrix metalloproteinases are an important class of ECM-associated enzymes that regulate the
degradation of ECM proteins and support tissue integrity during phases of collagen deposition
and muscle regeneration [19]. The main isoforms present in skeletal muscles are matrix
metalloproteinases MMP-1, MMP-2, MMP-9, MMP-10 and MMP-13 [20,21]. The tissue
inhibitors of matrix metalloproteinases, named TIMP, are endogenous regulatory factors
involved in the formation, adaptation and controlled degradation of the ECM [22]. TIMP
molecules play a crucial role in the migration and differentiation of muscle stem cells during
regeneration following cellular injury [19].
A large variety of proteoglycans fill the gaps between collagen molecules and thereby form an
integral part of the highly complex ECM structure. Proteoglycan molecules are highly
glycosylated with glycosaminoglycans at multiple sites along the peptide backbone [23].
Skeletal muscles contain small leucine-rich repeat proteoglycans (SLRP), heparan sulfate
proteoglycans and chondroitin sulphate proteoglycans. Muscle-associated proteoglycans of
the type SLRP are asporin, biglycan, decorin, mimecan (osteoglycin), fibromodulin and
lumican. Asporin is mostly found in the cartilage matrix. Biglycan is a small SLRP-type
proteoglycan that interacts with α-sarcoglycan and γ-sarcoglycan of the dystrophin-glyco‐
protein complex [24]. Decorin is the primary proteoglycan molecule of the perimysium and
tendon structures [25]. Fibromodulin is involved in collagen fibril formation, which is
illustrated by the biomedical fact that fibromodulin-deficient tendons exhibit abnormal
collagen fibrils [26]. The heparan sulfate proteoglycan syndecan is transiently up-regulated
during tissue differentiation and is involved in stem cell maintenance and muscle regeneration
[27]. Perlecan is located to the basement membrane and its expression is also transiently
increased during muscle differentiation [28]. The chondroitin sulphate proteoglycan named
aggrecan forms large aggregates in cartilage [29]. A proline-arginine-rich end leucine-rich
repeat protein (PRELP) is presented by prolargin of the basal lamina. At the highly differen‐
tiated neuromuscular junction region, the large proteoglycan molecule agrin is present and
forms via α-dystroglycan a tight linkage to the utrophin-glycoprotein complex. Agrin is
essential for the normal development of the neuromuscular junction and agrin-induced
clustering processes are crucial for the anchoring of the acetylcholine receptor complex in the
junctional folds [30].
3. Skeletal muscle development and the extracellular matrix
Skeletal muscle fibres derive from the mesoderm [31] and represent one of the most abundant
cell types in the body. Myofibres play a key physiological role in the provision and regulation
of locomotion, breathing, postural control, heat homeostasis and metabolic integration [32–
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34]. The development of contractile fibres is a highly complex process and changes in the ECM
play an essential role during myogenesis. Adaptations occur at the level of the basal lamina,
the interstitial ECM and the collagen-rich tendon and encompass a variety of fundamental
processes of development, such as the determination of cell fate, as well as proliferation, cell
division, patterning and tissue transitions [35]. The most critical developmental processes
occur during the initial activation of precursor cells, various differentiation steps and the final
maturation of innervated myofibres. These major developmental mechanisms are regulated
by a large number of genetic and signalling factors [36]. Many specialized extracellular
components are involved in muscle development, which is reflected by the transient expres‐
sion patterns of certain ECM molecules, such as the minor collagen isoforms COL XI, XII, XIV,
XV and XVIII [3].
The molecular and cellular events that occur during the establishment of the myogenic cell
lineage and resulting formation of multi-nucleated contractile fibres entail initially a fibrillar
and fibronectin-rich matrix. In developmental terms, almost all myofibres of the skeletal
musculature derive from mesodermal structures named somites that develop during early
embryonic segmentation on both sides of the neural tube [37–39]. The developing ECM of
somites is represented by a fibronectin core, a basement membrane and an outer fibronectin-
containing matrix [35]. Figure 3 outlines the initiation and control of embryonic and adult
myogenesis by myogenic factors and through a complex series of spatio-temporal dependent
signalling cascades. Fibronectin and its interactions with the integrin complex play a central
role in polarizing and guiding somitic cells [40–42] and the ECM is crucial for somite formation
and as a guiding cue during morphogenesis [43–45]. The small SLRP-type proteoglycan
decorin was shown to be majorly involved in skeletal muscle development by promoting
proliferation and differentiation of muscle cells through suppressing myostatin activity [46–
48].
The key regulator of early myogenesis that initiates the developmental commitment into the
myogenic cell lineage is the paired-type homeobox gene PAX3 [49–51]. Interestingly, another
member of the PAX transcription factor family, the PAX3 orthologue PAX7, acts as a regulator
of mature skeletal muscle regeneration and postnatal growth mechanisms [52]. Following the
induction of mesodermal precursors, the subsequent segmentation into somites and the
formation of the primary myotome involves a variety of signalling molecules and transcription
factors, such as the secreted and lipid-modified family of Wnt-glycoproteins and the large
group of myogenic basic helix-loop-helix muscle regulatory factors, such as MyoD, Myf5,
MRF4 and myogenin [53–55]. Myogenic factors act at multiple regulatory points during
embryonic myogenesis, whereby the overall genetic pathway that is responsible for the
transcriptional activation of skeletal muscle-specific genes is highly complex and partially
redundant [56]. A key step during muscle development is the fusion of myogenic cells that
result in the formation of innervated and multi-nucleated myofibres (Figure 3). Although
specific regulatory processes differ between embryonic, foetal, postnatal and mature regen‐
erative myogenesis [57], the basic biological mechanisms of skeletal muscle development and
injury-related adult muscle regeneration are extraordinarily similar [58,59]. A large pool of
satellite cells provides a high level of regenerative capacity of the matured post-mitotic fibres
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and is located between the sarcolemma and the basal lamina [60]. These mono-nucleated
myogenic stem cells are activated during cycles of fibre regeneration and cellular maintenance.
To provide maximum skeletal muscle performance, activated stem cells undergo a complex
pattern of proliferation, differentiation and cellular fusion to form multi-nucleated and
functional contractile myofibres [61]. Following maturation, the tissue mass of skeletal muscles
is then regulated by catabolic and anabolic mechanisms that include signalling factors such as
NF-kB and FoxO, as well as the mTOR pathway [62].
The systematic profiling of myogenesis using mass spectrometry-based proteomics has
covered postnatal growth and development [63,64], but focused mostly on studying cell
culture models [65–67] and specifically the skeletal muscle secretome during myoblast
differentiation and myotube formation [68–72]. The concept that skeletal muscle cells act as
secretory tissues has recently been reviewed by Pedersen [73]. Secreted myokines probably
exert autocrine, paracrine or endocrine effects within the neuromuscular system and also in
relation to other organ systems [74]. The skeletal muscle secretome is estimated to consist of
several hundred muscle-derived peptides and proteins [75]. During muscle development,
Figure 3. Outline of the initiation and control of embryonic and adult myogenesis. Shown is the transition from meso‐
dermal progenitor cells to myoblasts, followed by cellular fusion to produce multi-nucleated myotubes and finally in‐
nervated and functional myofibres. The critical role of stem cells during both embryonic development and
regeneration of injured adult muscle fibres is highlighted, as well as changes in the ECM. Fibronectin (FN) and its in‐
teractions with the integrin complex are of central importance for polarizing and guiding somitic cells and the proteo‐
glycan decorin is majorly involved in myogenesis by promoting proliferation and differentiation through supressing
myostatin activity. Changes in the ECM and the formation of a collagen (COL) matrix during muscle development are
marked.
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changes in ECM proteins have recently been studied in relation to human myogenesis and
established that altered protein expression underlies the dramatic phenotypic conversion of
primary mono-nucleated muscle cells during differentiation to form multi-nucleated myo‐
tubes [76]. The temporal profiling of the human myoblast proteome during in vitro differen‐
tiation highlighted the importance of ECM rearrangement during early myogenesis and
showed a drastic increase in key ECM components, including several α-isoforms of collagen
COL VI and COL XVIII, as well as the heparan sulfate proteoglycan HSPG2 of the basement
membrane, the elastin–microfibril interface–located ECM glycoprotein EMILIN2 and nidogen
isoform NID2 [76]. These findings confirm the developmental concept that enhanced synthesis
of ECM proteins occurs during the transition from myoblasts to syncytial myotubes [72] and
that complex interactions at the cell–ECM interface facilitate the fusion of myoblasts [35].
4. Mature fibres, skeletal muscle plasticity and the extracellular matrix
Both, proteomic cataloguing studies of various skeletal muscle specimens [77–82] and the
comparative expression profiling of crude skeletal muscle preparations or subcellular fractions
[83–86] routinely identify ECM proteins that form the core complexes of the basal lamina,
microfibrils and interstitial matrix [87]. Figure 4 shows a bioinformatics STRING [88] map of
core ECM components from skeletal muscles. In mature skeletal muscles, frequently identified
ECM molecules include collagens of the interstitial matrix (COL I, COL III and COL V), the
microfibrillar collagen isoform COL VI, the non-fibrillar collagen isoform COL IV of the
basement membrane, components of cell–ECM adhesion complexes (laminin, fibronectin,
integrins, dystrophin, utrophin), regulatory ECM proteins (dermatopontin, nidogen, periostin
and osteopontin), SLRP-type proteoglycans (asporin, biglycan, decorin, mimecan, fibromo‐
dulin and lumican), heparan sulfate proteoglycans (syndecan and perlecan), the chondroitin
sulphate proteoglycan aggrecan, the PRELP-type proteoglycan prolargin and the neuromus‐
cular junction-specific proteoglycan agrin, as well as matrix metalloproteinases and their
inhibitors (MMP-1, MMP-2, MMP-9, MMP-10, MMP-13 and TIMPs) [77–86]. Figure 4 includes
the protein products of the following genes: BGN, SDC1, HSPG2, AGRN, FN1, DAG1, ACAN,
DPT, POSTN, MMP1, MMP2, MMP9, MMP10, MMP13, TIMP1, COL1A1, COL1A2, COL6A1,
COL6A2, COL3A1, COL5A1, COL4A4, LAMA2, LAMB1, LAMB2, LAMC1, NID1, ASPN, PRELP,
PGS2, LUM, OGN, FMOD, ITGA7, ITGB1. This encompasses essential members of the various
collagen networks found in the basement membrane, the microfibrillar structures and the
interstitial matrix. In addition, major proteoglycans, matricellular proteins and matrix
metalloproteinases are shown, as well as the interaction sites between sarcolemmal adhesion
receptor complexes and the ECM.
Individual skeletal muscles are characterized by their fibre type distribution pattern whereby
the proportion of fast-twitching fibres, slow-twitching fibres and hybrid fibres is highly
adaptable and changes according to specific physiological, biochemical and/or metabolic
demands [89]. Alterations in physical activity affect the molecular and cellular composition of
the neuromuscular system, including hypertrophy, i.e. the increase in fibre size and hyper‐
plasia, i.e. the increase in fibre number [90]. The plasticity of the neuromuscular system is a
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well-established physiological concept. Endurance training is associated with an increased
aerobic capacity and elevated utilization of fatty acid oxidation [91]. In contrast, sprint training
triggers higher activities of the glycolytic and phosphocreatine pathways and enhances
carbohydrate metabolism [92]. Prior to systematic proteomic studies, a large number of
biochemical, cell biological and physiological studies have established ECM changes in
response to exercise [93–95], including collagens, adhesion receptors, growth factors, matri‐
cellular proteins and matrix metalloproteinases [96–100]. Neuromuscular unloading clearly
depresses collagen COL I and COL III production and reloading enhances collagen expression
in fast muscles [101]. The mass spectrometric analysis of exercise indicates proteome-wide
changes in the graded response of skeletal muscles to physical exercise using different training
regimes [102,103]. While moderate-intensity exercise causes a shift to a more fatigue-resistant
and a slower-contracting skeletal muscle phenotype, interval-exercise training is associated
with changes in post-translational modifications of metabolic enzymes [104–106]. The proteo‐
mic analysis of skeletal muscle plasticity in relation to acute versus chronic exercise was
recently determined using human vastus lateralis muscle biopsy specimens and label-free LC-
MS/MS analysis [107]. While structural and mitochondrial proteins were shown to be increased
after long-term exercise, components related to energy metabolism were decreased following
short-term exercise. Moderate ECM changes were described for several α-chains of collagen
VI, fibronectin and decorin [107].
Figure 4. Bioinformatics STRING map of major components that form the core of the extracellular matrix (ECM) com‐
plexome. Shown are key proteins belonging to the collagen network of the basal lamina, microfibrils and the intersti‐
tial matrix, proteoglycans, matricellular proteins and matrix metalloproteinases. The interaction sites of the ECM with
sarcolemmal adhesion receptor complexes are shown.
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An interesting non-physiological system is presented by external chronic low-frequency
stimulation of fast muscles. This electro-stimulation method causes the complete activation of
all affected motor units to a maximum extent [108]. During fast-to-slow transitions, skeletal
muscles show a remarkable adaptation and transform physiologically and biochemically into
motor units with an improved resistance to fatigue [109]. Chronic low-frequency stimulated
fast muscles are characterized by decreased fibre calibres, an increase in the time-to-peak
twitch tension, an increase in half-relaxation time and a significant elevation of aerobic-
oxidative capacity [110]. The proteomic analysis of continuous electro-stimulation at 10 Hz has
demonstrated complex biochemical changes with a significant shift from glycolytic to more
aerobic-oxidative metabolism [111,112]. The ECM of transforming skeletal muscle undergoes
distinct changes and exhibits increased collagen levels [113,114]. In the stimulated latissimus
dorsi model for testing the suitability of dynamic cardiomyoplasty to treat heart failure, the
collagen content was shown to be significantly elevated in the paced muscle. Although the
chronically electro-stimulated muscle increased the level of fatigue resistance, distal regions
of the paced latissimus dorsi muscle were characterized by muscular atrophy and myofibrosis
[114].
5. Neuromuscular disorders and the extracellular matrix
A general myopathological parameter of a variety of acquired and inherited muscle diseases
[115], as well as the gradual loss of contractile strength during the natural aging process [116],
is the progressive accumulation of ECM components, especially collagens [7]. Inflammatory
processes and tissue infiltration often accompany the loss of skeletal muscle fibres. Increased
levels of non-contractile entities, such as fibrous connective and fatty tissue, within the
neuromuscular system are a key pathological factor in the dysregulation of skeletal muscle
function. Myofibrosis often correlates with poor motor outcome in neuromuscular disorders,
such as the progressive loss of muscle strength and concomitant endomysial changes in the X-
linked inherited disorder Duchenne muscular dystrophy [117]. In muscle pathology, changes
in ECM components can be differentiated as being a consequence of a primary defect in the
matrisome of muscles, such as the ECM diseases Collagen IV myopathy [118,119] and LAMA2-
related congenital myopathy [120,121], or a secondary response in the form of reactive
myofibrosis, as is seen in dystrophinopathies [122,123].
The systematic profiling of changes in ECM components in Collagen IV myopathy and X-
linked muscular dystrophy has resulted in interesting new findings in relation to primary ECM
defects versus reactive fibrosis. Mutations in the genes encoding collagen isoform COL VI are
the underlying cause of the severe UCMD type of Ullrich congenital muscular dystrophy and
the milder BM type of Bethlem myopathy. Both disorders are characterized by skeletal muscle
wasting, cycles of cellular degeneration and regeneration, and the substitution of contractile
fibres with fat and connective tissue [119]. The cell biological and proteomic analysis of mouse
models and biopsy material from patients afflicted with Collagen IV myopathy revealed
metabolic dysregulation, enhanced cellular stress, autophagic impairment and alterations in
mechano-transduction signalling pathways [124,125]. In the case of X-linked muscular
dystrophy, a large number of proteomic studies have surveyed secondary changes down‐
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stream of the primary abnormality in the membrane cytoskeletal protein dystrophin [126].
Muscular dystrophy-related changes affect energy metabolism, cellular signalling, the
excitation–contraction–relaxation cycle, the stress response, the cytoskeletal network and the
ECM [127]. The recent proteomic profiling of established genetic animal models of dystro‐
phinopathy has revealed a drastic increase in various collagens, proteoglycans and matricel‐
lular proteins [83–86,128,129]. Figure 5 outlines the histo- and pathobiochemical consequences
of muscular changes and a hyperactive connective tissue in dystrophin-deficient skeletal
muscles.
The simultaneous mass spectrometric analysis of dystrophin isoform Dp427 and collagen in
moderately dystrophic mdx-4cv leg muscles revealed significant increases in collagens and
associated ECM proteins, such as fibronectin, biglycan, asporin, decorin, prolargin, mimecan
and lumican [85]. The pathoproteomic signature of the severely dystrophic mdx-4cv diaphragm
included a significant increase in collagens and the related ECM proteins asporin, decorin,
Figure 5. Overview of reactive myofibrosis in X-linked muscular dystrophy. The transforming growth factor TGF-β
and the activity of matrix metalloproteinases (MMP) and tissue inhibitors (TIMPs) play a crucial role in ECM activa‐
tion and modulation, which is characterized by increased levels of various collagens, proteoglycans, dermatopontin
and periostin. Progressive ECM accumulation triggers a chronic replacement of muscle fibres by fibrotic scar tissue
leading to a loss of muscle elasticity and contractile strength.
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dermatopontin, prolargin and periostin [83]. Especially interesting was the proteomic identi‐
fication of dermatopontin and periostin [83,128,129]. Dermatopontin, also named tyrosine-rich
acidic matrix protein TRAMP [130], is involved in matrix assembly and cell–matrix interactions
[17] via interactions with decorin, TGF-β and fibronectin [131]. High levels of dermatopontin
in the dystrophic mdx diaphragm most likely reflect an increased demand for collagen matrix
organization within Dp427-deficient fibres [128]. Periostin is a crucial matricellular protein of
93 kDa [18] that is involved in the regulation of the biomechanical properties of connective
tissues and collagen fibrillogenesis [132]. Normally periostin is only temporally expressed in
the muscle ECM during cellular differentiation and regeneration processes [133], making its
drastic up-regulation a characteristic feature of dystrophic muscles [83,86]. Of diagnostic and
therapeutic importance is the fact that muscle biopsies from Duchenne patients exhibit an
elevated concentration of periostin and that the deletion of periostin clearly reduces dystrophic
symptoms and myofibrosis in mice by modulating the TGF-β pathway [134]. Interestingly,
laminin-deficient muscular dystrophy also shows dysregulation of matricellular proteins as
an early pathophysiological feature [120,135]. Therefore altered levels of periostin and related
matricellular proteins are good biomarker candidates for the characterization of myofibrosis
in relation to inherited muscular dystrophies [136]. Although the natural aging process is also
associated with increased collagen levels [116], which were also shown by proteomics [137],
the collagen accumulation is much less pronounced in senescent muscles as compared to
muscular dystrophy.
6. Conclusions
In conclusion, a dynamic balance exists within the ECM system from skeletal muscles. Highly
regulated cycles of protein deposition, accumulation, remodelling and degradation occur in
response to development, fibre transformation, neuromuscular loading, mechanical unload‐
ing, disease processes or aging. The main components of the ECM are represented by collagen
fibres, non-fibrillar collagens, matricellular proteins, proteoglycans, matrix metalloproteinas‐
es, signalling molecules and adhesion complexes. The muscle ECM forms a structural scaffold
that plays a central role in the maintenance of the physical structure of motor units and
provides the framework for force transmission. The ECM is also involved in signalling
cascades and adhesion processes at the sarcolemma–matrix interface. The systematic mass
spectrometry-based proteomic analysis of the muscle ECM has established an enormous
complexity and interconnectivity of matrix proteins and confirmed the dynamic nature of
collagen networks and its associated proteoglycans in health and disease. Swift adaptations
or alterations in the arrangement of the ECM have been established to occur during myogen‐
esis, fibre regeneration, increased neuromuscular activity or pathological muscle wasting.
Hence, concentration changes in ECM proteins are useful indicators for studying basic cell
biological or pathophysiological processes in skeletal muscles. In the future, distinct ECM
molecules may be useful for designing improved diagnostic, prognostic or therapy-monitoring
approaches to study neuromuscular alterations.
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